Published in BMC Infect Dis on April 05, 2014
IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci Rep (2016) 0.80
QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study. BMC Infect Dis (2014) 0.79
Factors influencing innate immunity and vaccine responses in infancy. Philos Trans R Soc Lond B Biol Sci (2015) 0.77
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination. Front Immunol (2017) 0.75
Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 9.66
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr (1999) 4.57
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet (2002) 3.75
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Immunological biomarkers of tuberculosis. Nat Rev Immunol (2011) 2.88
The C-reactive protein. J Emerg Med (1999) 2.58
Update on technical issues concerning complementary feeding of young children in developing countries and implications for intervention programs. Food Nutr Bull (2003) 2.56
Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis (2001) 2.50
The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med (2011) 2.48
Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol (1996) 1.92
C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics (2001) 1.88
Zinc and the risk for infectious disease. Annu Rev Nutr (2004) 1.79
Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis (2009) 1.52
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis (2011) 1.21
Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine. Clin Infect Dis (1995) 1.19
The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine (2012) 1.08
Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur J Clin Nutr (2008) 1.06
Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb) (2009) 1.04
Inhibitory effects of isolated inositol phosphates on zinc absorption in humans. J Trace Elem Electrolytes Health Dis (1992) 1.00
Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children. Clin Vaccine Immunol (2013) 0.96
Zinc and immune function. Eur J Clin Nutr (2002) 0.94
Interleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants. Pediatrics (1998) 0.89
Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis (2013) 0.84
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet (2008) 5.93
UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis (2012) 5.42
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet (2013) 4.58
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet (2002) 3.75
Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med (2010) 3.53
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis (2006) 2.68
Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One (2010) 2.36
Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health (2010) 2.28
The effects of high HIV prevalence on orphanhood and living arrangements of children in Malawi, Tanzania, and South Africa. Popul Stud (Camb) (2007) 2.24
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS (2013) 2.06
From affected to infected? Orphanhood and HIV risk among female adolescents in urban Zimbabwe. AIDS (2008) 2.06
HIV and mortality of mothers and children: evidence from cohort studies in Uganda, Tanzania, and Malawi. Epidemiology (2005) 2.04
Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS (2007) 1.93
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Med (2008) 1.91
Age-specific mortality patterns in HIV-infected individuals: a comparative analysis of African community study data. AIDS (2007) 1.87
Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ (2004) 1.86
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS (2003) 1.83
The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis (2005) 1.79
High accuracy of home-based community rapid HIV testing in rural Malawi. J Acquir Immune Defic Syndr (2010) 1.73
Influence of placental malaria infection on foetal outcome in the Gambia: twenty years after Ian Mcgregor. J Health Popul Nutr (2002) 1.72
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis (2012) 1.69
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol (2009) 1.67
Trends in tuberculosis and the influence of HIV infection in northern Malawi, 1988-2001. AIDS (2004) 1.62
Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa. Trop Med Int Health (2012) 1.62
Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg (2004) 1.61
Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol (2010) 1.57
Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One (2009) 1.56
Use of data from HIV counselling and testing services for HIV surveillance in Africa. Lancet (2007) 1.54
Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS (2010) 1.52
Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. J Infect Dis (2009) 1.52
What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health (2010) 1.51
Is education the link between orphanhood and HIV/HSV-2 risk among female adolescents in urban Zimbabwe? Soc Sci Med (2009) 1.50
Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg Infect Dis (2006) 1.49
Proliferative lifespan is conserved after nuclear transfer. Nat Cell Biol (2003) 1.49
Distribution of environmental mycobacteria in Karonga District, northern Malawi. Appl Environ Microbiol (2006) 1.47
Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods (2002) 1.47
Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis (2004) 1.45
DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error? J Infect Dis (2004) 1.43
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. PLoS One (2013) 1.43
Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol (2010) 1.42
Individual, household and community factors associated with HIV test refusal in rural Malawi. Trop Med Int Health (2008) 1.41
Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog (2010) 1.41
Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg Infect Dis (2005) 1.40
Measuring concurrency: an empirical study of different methods in a large population-based survey and evaluation of the UNAIDS guidelines. AIDS (2012) 1.40
Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'. Trans R Soc Trop Med Hyg (2008) 1.40
Age at menarche, schooling, and sexual debut in northern Malawi. PLoS One (2010) 1.39
Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS One (2011) 1.38
Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health (2012) 1.38
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J Clin Microbiol (2010) 1.33
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun (2007) 1.33
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies. Trop Med Int Health (2012) 1.32
Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS One (2013) 1.32
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis (2007) 1.31
Persistence of the immune response induced by BCG vaccination. BMC Infect Dis (2008) 1.29
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. PLoS One (2008) 1.25
Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol (2005) 1.24
Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc (2011) 1.22
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis (2011) 1.21